logo
  

IDEXX Labs Lifts FY21 Earnings View; Tightens Revenue Forecast

While announcing higher third -quarter results, IDEXX Laboratories, Inc. (IDXX), a veterinary diagnostics provider, raised its forecast for fiscal 2021, inline or below market estimates. Further, the company tightened revenues outlook.

The company now expects full-year earnings per share of $8.30 - $8.38, higher than previous estimate of $8.20 - $8.36. Earnings per share for the year is now expected to grow 24 percent to 25 percent from last year on a reported basis and 26 percent to 27 percent on a comparable basis.

The company previously expected earnings per share for the year to grow 22 percent to 25 percent from last year.

Further, the company now expects revenues of $3.185 billion to $3.200 billion, compared to earlier expected $3.170 billion to $3.205 billion.

On average, analysts polled by Thomson Reuters expect earnings of $8.38 per share on revenues of $3.2 billion. Analysts' estimates typically exclude special items.

The updated view now reflects revenue growth of 17.5 percent to 18 percent on a reported basis and 15.5 percent to 16 percent organic. The previous expectations were reported growth of 17 percent to 18.5 percent and organic growth of 14.5 percent - 16 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. may face production shortfall of as many as 6 million iPhone Pro units this year due to ongoing protests at its major China plant, Bloomberg reported citing a person familiar with assembly operations. Following the news, Apple shares were losing around 2.2 percent in pre-market activity on the Nasdaq. Despite fears of inflation, consumers spent $9.12 billion for online shopping during Black Friday, higher than in previous years, as per a report published by Adobe Analytics. During the 2022 holiday season, total estimated revenues are $209.7 billion, a growth of 2.5 percent from last year's recorded revenues of $205 billion. Weis Markets, Inc., a Mid Atlantic food retailer, has recalled 108 containers of Weis Quality Sea Salt Caramel Ripple Ice Cream citing possible presence of undeclared soy and coconut allergens, the U.S. Food and Drug Administration said. The recalled product comes in 48oz containers that says Weis Quality Sea Salt Caramel Ripple Ice Cream, while the lid says Weis Quality Caramel Caribou Ice Cream
RELATED NEWS
Follow RTT